DKSC (Dakshidin) Interest Expense: $ Mil (TTM As of Sep. 2023)


What is Dakshidin Interest Expense?

Dakshidin DKSC +33.33% Interest Expense is $ Mil as of Sep. 2023.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Dakshidin's interest expense for the three months ended in Sep. 2023 was $ 0.00 Mil. Dakshidin does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Sep. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Dakshidin's Operating Income for the three months ended in Sep. 2023 was $ -0.00 Mil. Dakshidin's Interest Expense for the three months ended in Sep. 2023 was $ 0.00 Mil. Dakshidin has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


Dakshidin  (OTCPK:DKSC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dakshidin's Interest Expense for the three months ended in Sep. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was $0.00 Mil.

Dakshidin's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Dakshidin had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Dakshidin Interest Expense Historical Data

* Premium members only.

The historical data trend for Dakshidin's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Interest Expense Chart

Dakshidin Annual Data
Trend
Interest Expense

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Interest Expense 0.00 0.00 0.00 0.00

Dakshidin Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Dakshidin (DKSC) has a Interest Expense of $ Mil as of Sep. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Dakshidin and its competitors.
Is Dakshidin's Interest Expense too high?
Dakshidin's current Interest Expense is $ Mil.
How does Dakshidin's Interest Expense compare to ECEZ and AFBG?
Dakshidin's Interest Expense of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Dakshidin and its competitors. Dakshidin's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Dakshidin (DKSC), the current Interest Expense is $ Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.